🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I trial studies the side effects and best dose of genetically mo...
Status
Active Not Recruiting
Location
City of Hope Medical Center
Start Date
2013-10-08
Trial ID
NCT01815749
This phase II trial studies how well daratumumab, ixazomib, and dexamethaso...
Status
Unknown
Location
Emory University Hospital/Winship Cancer Institute
Start Date
2019-07-03
Trial ID
NCT03942224
Treatments Being Tested
In this trial the investigators aim to evaluate safety and efficacy of comb...
Status
Withdrawn
Location
Yale Cancer Center
Start Date
2020-02-12
Trial ID
NCT04044209
This study aims to evaluate the efficacy and safety of tafasitamab combined...
Status
Active Not Recruiting
Location
The First Affiliated Hospital of Soochow University
Start Date
2026-01-01
Trial ID
NCT07621406
Patients with CD30 positive DLBCL, primary refractory or in first relapse a...
Status
Recruiting
Location
NL-Rotterdam-ERASMUSMC
Start Date
2018-03-05
Trial ID
NCT03356054
Treatments Being Tested
This study will examine whether 240 µg/kg plerixafor given alone for up to ...
Status
Terminated
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2004-11
Trial ID
NCT00396383
Treatments Being Tested
Recent studies of conventional chemotherapy for infants with high-risk hema...
Status
Completed
Location
St. Jude Children's Research Hospital
Start Date
2004-05
Trial ID
NCT00145626
Treatments Being Tested
To investigate the feasibility of delivering oral azacitidine (CC-486) as a...
Status
Withdrawn
Location
Yale Comprehensive Cancer Center
Start Date
2023-11
Trial ID
NCT06180863
Treatments Being Tested
This is a multi-site phase 1 study of the safety, immunologic and virologic...
Status
Active Not Recruiting
Location
Johns Hopkins University(Jhu)
Start Date
2020-05-01
Trial ID
NCT04248192
Treatments Being Tested
The purpose of the study is to determine the best treatment approach based ...
Status
Not Yet Recruiting
Location
Beth Israel Deaconess Medical Center (BIDMC)
Start Date
2026-06-08
Trial ID
NCT07624513